Medtech availability a factor in Canadian wait time plan
This article was originally published in Clinica
The Canadian Wait Time Alliance (WTA), consisting of six specialty medical associations, has released an interim report on what it considers to be medically acceptable wait times. The report sets out "first principles" to benchmark the setting of wait-times for cardiac care, cancer care, diagnostic imaging, joint replacement and sight restoration, areas prioritised in the first ministers' 2004 10-year plan.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.